Advisor Group Holdings, Inc. Aprea Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	SELL	$0.32 - $15.2 $2,104 - $99,985	-6,578 Reduced 56.57%	5,050 $1,000
Q2 2022 Aug 10, 2022	BUY	$0.62 - $1.94 $6,558 - $20,521	10,578 Added 1007.43%	11,628 $9,000
Q1 2022 May 04, 2022	BUY	$1.59 - $3.16 $397 - $790	250 Added 31.25%	1,050 $2,000
Q1 2021 May 13, 2021	BUY	$4.73 - $8.15 $3,784 - $6,520	800 New	800 $4,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,589
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.